Work

Abstract PS2-04: Evaluating serum thymidine kinase 1 in hormone receptor positive metastatic breast cancer patients receiving first line endocrine therapy in the SWOG S0226 trial

Year: 2021

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs20-ps2-04

Authors: Costanza Paoletti, William E. Barlow, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai, Priyanka Sharma, Andrew K. Godwin, Alastair M. Thompson, Daniel F. Hayes, James Rae

Institutions: University of Michigan, U-M Rogel Cancer Center, Biovica (Sweden), University of California, Irvine Medical Center, Seattle Cancer Care Alliance, University of Washington Medical Center, The University of Texas MD Anderson Cancer Center, Loyola University Chicago, University of Kansas Medical Center, Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3132562078

Cites:

Cited by: 2

Related to: 10